Europe Lung Cancer Diagnostics Market to 2032
Overview
The Europe Lung Cancer Diagnostics Market is expected to reach a 2,464.94 USD Billion by 2032 and is projected to grow at a CAGR of 19.07% from 2025 to 2032.
Revenue, 2024 (USD Billion)
887.54
Forecast, 2032 (USD Billion)
2,464.94
CAGR, 2024 - 2032
19.07%
Report Coverage
Europe
Europe Lung Cancer Diagnostics Market 2018-2032 USD Billion
Europe Lung Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 887.54 USD Billion
- Projected Market Size (2032): 2,464.94 USD Billion
- CAGR (2025-2032): 19.07%
Key Findings of Europe Lung Cancer Diagnostics Market
- The Europe Lung Cancer Diagnostics Market was valued at 887.54 USD Billion in 2024.
- The Europe Lung Cancer Diagnostics Market is likely to grow at a CAGR of 19.07% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Non-Small Cell Lung Cancer in Cancer Segment accounted for the largest share of the market with a revenue of 678.86 USD Billion
- The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 21.61% during the forecast period from 2024 to 2032.
Europe Lung Cancer Diagnostics Market Scope
Europe Lung Cancer Diagnostics Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
Test
- Others
- Blood Test
- Biopsy
- Biomarkers Test
- Imaging Test
Product
- Consumables & Accessories
- Instruments
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospital
Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
Europe Lung Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 887.54 USD Billion |
| Market Value in 2032 | 2,464.94 USD Billion |
| CAGR (2025-2032) | 19.07% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,Test,Product,End User,Cancer |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 887.54 USD Billion in 2024
- Key Country: Germany, leading in terms of revenue with value of 216.51 USD Billion in 2024.
Segments and Scope
-
Europe Lung Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Europe Lung Cancer Diagnostics Market to 2032 with a revenue of 488.78 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Europe Lung Cancer Diagnostics Market to 2032 with a Growth rate of 20.37 % in forecast period 2025-2032.
-
Europe Lung Cancer Diagnostics Market to 2032, By Test
- Imaging Test is the largest segment in Europe Lung Cancer Diagnostics Market to 2032 with a revenue of 429.24 USD Billion in the year 2024.
- Imaging Test is the Fastest growing segment in Europe Lung Cancer Diagnostics Market to 2032 with a Growth rate of 20.20 % in forecast period 2025-2032.
-
Europe Lung Cancer Diagnostics Market to 2032, By Product
- Instruments is the largest segment in Europe Lung Cancer Diagnostics Market to 2032 with a revenue of 559.50 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in Europe Lung Cancer Diagnostics Market to 2032 with a Growth rate of 20.01 % in forecast period 2025-2032.
-
Europe Lung Cancer Diagnostics Market to 2032, By End User
- Hospital is the largest segment in Europe Lung Cancer Diagnostics Market to 2032 with a revenue of 223.98 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in Europe Lung Cancer Diagnostics Market to 2032 with a Growth rate of 21.61 % in forecast period 2025-2032.
-
Europe Lung Cancer Diagnostics Market to 2032, By Cancer
- Non-Small Cell Lung Cancer is the largest segment in Europe Lung Cancer Diagnostics Market to 2032 with a revenue of 678.86 USD Billion in the year 2024.
- Non-Small Cell Lung Cancer is the Fastest growing segment in Europe Lung Cancer Diagnostics Market to 2032 with a Growth rate of 19.31 % in forecast period 2025-2032.
Europe Lung Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Bio-Rad Laboratories, Inc. | |||
| Abbott | |||
| Guardant Health | |||
Europe Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion
Europe Lung Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,Test,Product,End User,Cancer.
Europe Lung Cancer Diagnostics Market was valued at USD 887.54(Revenue in USD Billion) in 2021.
Europe Lung Cancer Diagnostics Market is projected to grow at a CAGR of 19.07% during the forecast period of 2024 to 2032.
The Non-Small Cell Lung Cancer segment is expected to dominate the Europe Lung Cancer Diagnostics Market, holding a largest market share of 678.86 USD Billion in 2024
Europe Lung Cancer Diagnostics Market Scope
Europe Lung Cancer Diagnostics Market Segmentation & Scope
Distribution Channel
- Retail Sales
- Direct Tender
Test
- Others
- Blood Test
- Biopsy
- Biomarkers Test
- Imaging Test
Product
- Consumables & Accessories
- Instruments
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospital
Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
Frequently Asked Questions
The Europe Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,Test,Product,End User,Cancer.
Europe Lung Cancer Diagnostics Market was valued at USD 887.54(Revenue in USD Billion) in 2021.
Europe Lung Cancer Diagnostics Market is projected to grow at a CAGR of 19.07% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Lung Cancer Diagnostics Market for final year is USD 2,464.94 (USD Billion).
Europe Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Europe Lung Cancer Diagnostics Market is segmented based on Segmentation Distribution Channel,Test,Product,End User,Cancer.
Europe Lung Cancer Diagnostics Market was valued at USD 887.54(Revenue in USD Billion) in 2021.
Europe Lung Cancer Diagnostics Market is projected to grow at a CAGR of 19.07% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Lung Cancer Diagnostics Market for final year is USD 2,464.94 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.